Cellectar Biosciences, Inc. (CLRB)
3.04
+0.22
(+7.80%)
USD |
NASDAQ |
Feb 06, 16:00
3.06
+0.02
(+0.66%)
After-Hours: 20:00
Cellectar Biosciences SG&A Expense (TTM) : 15.48M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Imunon, Inc. | 7.011M |
| PDS Biotechnology Corp. | 13.08M |
| PAVmed, Inc. | 16.57M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |